Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

ACRV Financial Statements and Analysis

NASDAQ : ACRV

Acrivon Therapeutics, Inc. Common Stock

$5.28
0.21+414.20%
Open: 2:31 PM
57.29
BESG ScoreESG Rating

ACRV FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

ACRV Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

DateSep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue00000
cost of revenue0200.00K224.00K149.00K331.00K
gross profit0-200.00K-224.00K-149.00K-331.00K
gross profit ratio00000
research and development expenses18.864M15.025M11.249M15.329M10.267M
general and administrative expenses6.276M6.412M6.195M5.575M5.87M
selling and marketing expenses00000
selling general and administrative expenses6.276M6.412M6.195M5.575M5.87M
other expenses00-264.00K1.801M1.671M
operating expenses25.14M21.437M17.444M20.904M16.137M
cost and expenses25.14M21.437M17.668M21.053M16.137M
interest income2.698M2.694M1.446M00
interest expense00000
depreciation and amortization0228.00K224.00K149.00K133.00K
ebitda-25.14M-21.437M-17.444M-20.904M-16.137M
ebitda ratio00000
operating income-25.14M-21.437M-17.668M-21.053M-16.137M
operating income ratio00000
total other income expenses net2.699M2.639M1.182M1.801M1.671M
income before tax-22.441M-18.798M-16.486M-19.252M-14.466M
income before tax ratio00000
income tax expense00180.724K0-133.00K
net income-22.441M-18.798M-16.486M-19.252M-14.466M
net income ratio00000
eps-0.59-0.52-0.73-0.86-0.66
eps diluted-0.59-0.52-0.73-0.86-0.66
weighted average shs out38.105M36.133M22.591M22.335M22.081M
weighted average shs out dil38.105M36.133M22.591M22.335M22.081M
Graph

ACRV Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

DateSep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents43.415M46.006M24.607M36.015M29.859M
short term investments144.038M134.531M85.368M91.443M112.231M
cash and short term investments187.453M180.537M109.975M127.458M142.09M
net receivables00000
inventory00000
other current assets1.531M1.821M2.168M2.234M2.402M
total current assets188.984M182.358M112.143M129.692M144.492M
property plant equipment net8.467M7.443M7.613M7.908M6.189M
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments15.39M40.316M417.00K414.00K411.00K
tax assets00000
other non current assets1.843M468.00K348.00K250.999K0
total non current assets25.70M48.227M8.378M8.573M6.60M
other assets0001.000
total assets214.684M230.585M120.521M138.265M151.092M
account payables1.506M1.261M2.056M5.048M1.504M
short term debt1.04M1.956M944.00K877.00K776.00K
tax payables00000
deferred revenue00000
other current liabilities12.273M8.067M6.041M7.378M7.019M
total current liabilities14.819M11.284M9.041M13.303M9.299M
long term debt2.973M3.243M3.501M3.767M3.644M
deferred revenue non current00000
deferred tax liabilities non current00000
other non current liabilities00-1.00-1.000
total non current liabilities2.973M3.243M3.501M3.767M3.644M
other liabilities001.001.000
capital lease obligations4.013M4.221M3.501M3.767M4.42M
total liabilities17.792M14.527M12.542M17.07M12.943M
preferred stock00000
common stock31.00K31.00K23.00K23.00K22.00K
retained earnings-174.145M-151.704M-132.906M-116.42M-97.168M
accumulated other comprehensive income loss782.00K-19.00K-70.00K-83.00K-302.00K
other total stockholders equity370.224M367.75M240.932M237.675M235.597M
total stockholders equity196.892M216.058M107.979M121.195M138.149M
total equity196.892M216.058M107.979M121.195M138.149M
total liabilities and stockholders equity214.684M230.585M120.521M138.265M151.092M
minority interest00000
total investments159.428M174.847M85.785M91.857M112.231M
total debt4.013M4.221M4.445M4.644M4.42M
net debt-39.402M-41.785M-20.162M-31.371M-25.439M
Graph

ACRV Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

DateJun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax00-186.00K-742.00K-768.00K
stock based compensation3.566M3.344M3.058M3.228M2.686M
change in working capital1.971M-3.812M4.165M1.843M2.56M
accounts receivables00000
inventory00000
accounts payables-943.00K-2.272M3.17M76.00K-107.00K
other working capital2.914M-1.54M995.00K1.767M2.667M
other non cash items4.067M5.711M-300.00K198.00K195.00K
net cash provided by operating activities-13.903M-17.083M-12.366M-9.806M-9.112M
investments in property plant and equipment-137.00K-815.00K-1.151M0-112.00K
acquisitions net00000
purchases of investments-134.832M-28.335M-16.581M-22.984M0
sales maturities of investments46.925M35.00M38.268M24.50M19.45M
other investing activites00000
net cash used for investing activites-88.044M5.85M20.536M1.516M19.338M
debt repayment00000
common stock issued123.86M-6.00K-714.00K78.00K379.00K
common stock repurchased00000
dividends paid00000
other financing activites-510.00K-166.00K-1.297M00
net cash used provided by financing activities123.35M-172.00K-2.011M78.00K379.00K
effect of forex changes on cash00-3.00K12.372M-7.386M
net change in cash21.399M-11.408M6.156M-8.212M10.605M
cash at end of period46.006M24.607M36.015M30.27M38.482M
cash at beginning of period24.607M36.015M29.859M38.482M27.877M
operating cashflow-13.903M-17.083M-12.366M-9.806M-9.112M
capital expenditure-137.00K-815.00K-1.151M0-112.00K
free cash flow-14.04M-17.898M-13.517M-9.806M-9.224M
Graph

Frequently Asked Questions

How did Acrivon Therapeutics, Inc. Common Stock do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, ACRV generated $0.00 in revenue last quarter, while its costs came in at $0.00.
Last quarter, how much Gross Profit did Acrivon Therapeutics, Inc. Common Stock report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Acrivon Therapeutics, Inc. Common Stock reported a $0.00 Gross Profit for the quarter ended Jun 30, 2024.
Have ACRV's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. ACRV incurred $25.14M worth of Operating Expenses, while it generated -$25.14M worth of Operating Income.
How much Net Income has ACRV posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Acrivon Therapeutics, Inc. Common Stock, the company generated -$22.44M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did Acrivon Therapeutics, Inc. Common Stock have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Acrivon Therapeutics, Inc. Common Stock as of the end of the last quarter was $43.42M.
What are ACRV's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, ACRV had Total Net Receivables of $0.00.
In terms of Total Assets and Current Assets, where did Acrivon Therapeutics, Inc. Common Stock stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of ACRV were $188.98M, while the Total Assets stand at $214.68M.
As of the last quarter, how much Total Debt did Acrivon Therapeutics, Inc. Common Stock have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of ACRV's debt was $4.01M at the end of the last quarter.
What were ACRV's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, ACRV reported total liabilities of $17.79M.
How much did ACRV's Working Capital change over the last quarter?
Working Capital Change for ACRV was $1.97M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
ACRV generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. ACRV generated -$13.90M of Cash from Operating Activities during its recently reported quarter.
What was ACRV's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. ACRV reported a $21.40M Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph